Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Gilead Sciences, Inc. (GILD) had Revenue of $6.67B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$6.67B
Net Income	$1.31B
Cost of Goods Sold	$1.54B
Gross Profit	$5.13B
Operating Expenses	$4.43B
Operating Income	$2.24B
Non-Operating Income/Expense	$-588.00M
Pre-Tax Income	$1.65B
Normalized Pre-Tax Income	$1.65B
Income after Taxes	$1.31B
Income from Continuous Operations	$1.31B
Consolidated Net Income/Loss	$1.31B
Normalized Income after Taxes	$1.31B
EBIT	$2.24B
EBITDA	$2.93B
Weighted-Average Shares Outstanding (Basic)	1.25B
Weighted-Average Shares Outstanding (Diluted)	1.26B
Earnings per Share (EPS) (Basic)	$1.06
Earnings per Share (EPS) (Diluted)	$1.04
Balance Sheet Financials
Current Assets	$16.90B
Property, Plant, and Equipment	$5.42B
Long-Term Assets	$39.53B
Total Assets	$56.43B
Current Liabilities	$12.34B
Long-Term Debt	$22.15B
Long-Term Liabilities	$25.01B
Total Liabilities	$37.36B
Common Equity	$19.08B
Tangible Shareholders Equity	$-8.59B
Shareholders Equity	$19.08B
Common Shares Outstanding	1.25B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.76B
Cash Flow from Investing Activities	$-415.00M
Cash Flow from Financial Activities	$-3.43B
Beginning Cash	$9.99B
End Cash	$7.93B
Increase/Decrease in Cash	$-2.06B
Stock-Based Compensation	$209.00M
Common Stock Dividends Paid	$-1.01B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.31
Gross Margin	76.90%
Operating Margin	33.55%
EBIT Margin	33.55%
EBITDA Margin	--
Pre-Tax Profit Margin	24.73%
Profit Margin	19.72%
Free Cash Flow	$1.65B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.88
Receiveable Turnover	1.52
Days Sales in Receivables	59.23
Return on Equity	6.89%
Return on Tangible Equity	-15.31%
Return on Assets	2.33%
Return on Investments	3.19%
Book Value Per Share	$15.32
Free Cash Flow per Share	$1.31
Operating Cash Flow per Share	$1.40

Data from Zacks Investment Research, Inc.